As the FDA enforces the requirement for electronic data submission using SEND, pharmaceutical and biotech companies must adapt to this data-driven paradigm. PointCross Life Sciences emerges as a trusted partner, offering cloud-hosted or on-premises non-clinical solutions that streamline the process of becoming SEND ready. Embracing PointCross solutions empowers organizations to comply with regulatory mandates efficiently, optimize data management, and stay ahead of the curve in an increasingly data-centric industry. Contact PointCross today and embark on a seamless journey towards compliance with the FDA’s SEND mandate.
Related Posts
The Molecular Medicine Tri Con Conference 2018
Feb 11 – 16, 2018 | San Francisco, CA | Booth # 732 read more
SEND-ASSURE ensures FDA submission data consistency
PointCross announces SEND ASSURE for Data Consistency in Submissions to the FDA SEND-ASSURE is an audit solution to reduce risks... read more
Visualization of “Real Time” Data from Ongoing Non-Clinical Studies in Support of Study Monitoring and informed Decision Making
PointCross will be holding a joint presentation with Roche | 9th–13th November read more
Bay Area Biotech-Pharma Statistics Workshop (BBSW)
We’re excited to announce that PointCross is sponsoring the Bay Area Biostatistics & Bioinformatics Symposium (BBSW) 2024. Date: October 24-25,... read more